EUROFINS SCIENT Cash on Hand 2018-2025 | ERFSF
EUROFINS SCIENT cash on hand from 2018 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- EUROFINS SCIENT cash on hand for the quarter ending June 30, 2025 was $0.666B, a 13.59% decline year-over-year.
- EUROFINS SCIENT cash on hand for 2024 was $0.666B, a 49.75% decline from 2023.
- EUROFINS SCIENT cash on hand for 2023 was $1.326B, a 155.77% increase from 2022.
- EUROFINS SCIENT cash on hand for 2022 was $0.519B, a 15.02% decline from 2021.
| EUROFINS SCIENT Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $666 |
| 2023 | $1,326 |
| 2022 | $519 |
| 2021 | $610 |
| 2020 | $1,042 |
| 2019 | $333 |
| 2018 | $653 |
| 2017 | $1,030 |
| 2016 | $0 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $666 |
| 2023-06-30 | $755 |
| 2022-12-31 | $519 |
| 2021-12-31 | $610 |
| 2021-06-30 | $771 |
| 2020-12-31 | $1,042 |
| 2020-06-30 | $678 |
| 2019-12-31 | $333 |
| 2019-06-30 | $343 |
| 2018-12-31 | $653 |
| 2018-06-30 | $786 |
| 2017-12-31 | $1,030 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.728B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.699B | 26.28 |
| CVS Health (CVS) | United States | $78.241B | 9.72 |
| Elevance Health (ELV) | United States | $66.788B | 8.98 |
| Cencora (COR) | United States | $56.876B | 19.79 |
| DiDi Global (DIDIY) | China | $27.957B | 29.70 |
| Labcorp Holdings (LH) | United States | $20.968B | 17.01 |
| Natera (NTRA) | United States | $18.819B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| ICON (ICLR) | Ireland | $13.558B | 13.05 |
| CochLear (CHEOY) | Australia | $13.493B | 0.00 |
| Solventum (SOLV) | United States | $12.872B | 13.63 |
| Medpace Holdings (MEDP) | United States | $12.288B | 32.52 |
| Revvity (RVTY) | United States | $11.722B | 20.17 |
| Viatris (VTRS) | United States | $10.997B | 3.78 |
| Avantor (AVTR) | United States | $9.267B | 13.47 |
| Sonic Healthcare (SKHHY) | Australia | $9.129B | 0.00 |
| HealthEquity (HQY) | United States | $8.380B | 36.71 |
| Charles River Laboratories (CRL) | United States | $8.249B | 16.17 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.640B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.038B | 29.67 |
| BrightSpring Health Services (BTSG) | United States | $3.745B | 34.35 |
| Sotera Health (SHC) | United States | $3.364B | 19.11 |
| Surgery Partners (SGRY) | United States | $2.848B | 37.03 |
| Organon (OGN) | United States | $2.626B | 2.79 |
| Concentras Parent (CON) | United States | $2.584B | 14.93 |
| Alignment Healthcare (ALHC) | United States | $2.453B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.367B | 91.15 |
| Progyny (PGNY) | United States | $2.011B | 44.26 |
| PACS (PACS) | United States | $1.821B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.800B | 36.00 |
| Premier (PINC) | United States | $1.761B | 13.37 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.249B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.126B | 8.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.999B | 342.50 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.786B | 7.35 |
| CareDx (CDNA) | United States | $0.731B | 11.41 |
| Embecta (EMBC) | United States | $0.680B | 4.58 |
| So-Young (SY) | China | $0.557B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.540B | 0.00 |
| Nutex Health (NUTX) | United States | $0.516B | 7.81 |
| SBC Medicals (SBC) | United States | $0.510B | 0.00 |
| Omada Health (OMDA) | $0.496B | 0.00 | |
| LifeMD (LFMD) | United States | $0.493B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.432B | 0.00 |
| Enhabit (EHAB) | United States | $0.350B | 28.83 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Beauty Health (SKIN) | United States | $0.255B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.155B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.117B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |